Scarica l'app Stockscreener
12.66
4.20%
0.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$12.15
Aprire:
$12.2
Volume 24 ore:
1.96M
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.93B
Reddito:
$177.28M
Utile/perdita netta:
$-195.24M
Rapporto P/E:
-9.4478
EPS:
-1.34
Flusso di cassa netto:
$-114.54M
1 W Prestazione:
+14.57%
1M Prestazione:
+7.11%
6M Prestazione:
+67.68%
1 anno Prestazione:
+194.42%
Intervallo 1D:
$12.18
$12.93
Intervallo di 1 settimana:
$10.65
$12.93
Portata 52W:
$3.981
$12.93
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
12.66 | 1.85B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year? - Nasdaq
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Just Reported And Analysts Have Been Lifting Their Price Targets - ca.finance.yahoo.com
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences - 富途牛牛
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $14 to $15 - 富途牛牛
Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Over - GuruFocus
JP Morgan Boosts Price Target for ADPT to $14.00, Maintains Overweight Rating | ADPT Stock News - GuruFocus
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday - Yahoo Finance
JP Morgan Maintains Overweight on Adaptive, Raises PT to $14 from $10 - AInvest
Adaptive Biotechnologies (ADPT) Rating Update: TD Cowen Raises Price Target | ADPT Stock News - GuruFocus
TD Cowen Keeps Buy Rating, Raises PT to $15 on Adaptive Biotechnologies - AInvest
Piper Sandler Raises Price Target for ADPT to $15.00 | ADPT Stock News - GuruFocus
A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $11 to $15 - 富途牛牛
Adaptive Biotechnologies stock hits 52-week high at $12.50 - Investing.com India
Adaptive Biotechnologies stock hits 52-week high at $12.50 By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies (ADPT) Price Target Increased by JPMorg - GuruFocus
Adaptive Biotechnologies Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Adaptive Biotechnologies: Q2 Earnings Snapshot - New Haven Register
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ... By GuruFocus - Investing.com Canada
Advanced analytics toolkit walkthrough for Adaptive Biotechnologies CorporationFree Swing Trading Entry Point Signals - Newser
Adaptive Biotechnologies Q2 2025 slides: MRD business achieves profitability milestone - Investing.com Nigeria
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings - Yahoo Finance
Adaptive Biotechnologies’ MRD Business Powers Past Expectations - Finimize
Adaptive Biotechnologies (ADPT) Surpasses Revenue Expectations i - GuruFocus
Earnings call transcript: Adaptive Biotechnologies beats Q2 2025 forecasts By Investing.com - Investing.com Australia
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Adaptive Biotechnologies beats Q2 2025 forecasts - Investing.com
Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability - Investing.com
Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability By Investing.com - Investing.com UK
Adaptive Biotechnologies earnings beat by $0.07, revenue topped estimates - Investing.com South Africa
Adaptive Biotechnologies Corp SEC 10-Q Report - TradingView
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results - TradingView
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesFree Consistent Gain Investment Strategies - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationFundamental Analysis for Value Stock Selection - Newser
Adaptive Biotechnologies Corp (ADPT) Q2 2025: Everything You Nee - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Craig-Hallum Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating - 富途牛牛
Using AI based signals to follow Adaptive Biotechnologies CorporationCapital Growth Plan for New Investors - Newser
Real time scanner hits for Adaptive Biotechnologies Corporation explained - Newser
What is the dividend policy of Adaptive Biotechnologies Corporation stockAchieve rapid financial growth with smart picks - Jammu Links News
Visual trend scoring systems applied to Adaptive Biotechnologies CorporationFree Entry Zone Strategy for Consistent Profit - newser.com
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):